Next generation malaria vaccine trial passes first hurdle with strong results

Next generation malaria vaccine trial passes first hurdle with strong results

A ‘next generation’ vaccine for malaria has shown success in its first human trial. The phase 1 study saw a strong immune response in 10 healthy volunteers. The vaccine was created by genetically engineering the malaria parasite to make it weaker. Scientist removed the three genes needed for it to successfully infect and cause disease in humans. None of the participants developed malaria symptoms, and showed a strong protective antibody response. Jan 5, 2017
What is Fat Cat Wednesday?

What is Fat Cat Wednesday?

Fat Cat Wednesday is a day where FTSE 100 bosses will have already earned more than the average worker in the UK makes all year. Jan 4, 2017
Should you invest in gold in 2017?

Should you invest in gold in 2017?

Gold investment demand tends to go up when the world economy is uncertain and volatile. IBTimes UK expert financial columnist Edmund Shing asks whether 2017 could be the time to invest in gold. Jan 4, 2017
MOST POPULAR